Analytical Data
-
基因名
C1qB
- Application
-
别名
C1qB；Complement C1q subcomponent subunit B
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P02746
-
表达区间
1-253aa
-
氨基酸序列
MMMKIPWGSIPVLMLLLLLGLIDISQAQLSCTGPPAIPGIPGIPGTPGPD GQPGTPGIKGEKGLPGLAGDHGEFGEKGDPGIPGNPGKVGPKGPMGPKGG PGAPGAPGPKGESGDYKATQKIAFSATRTINVPLRRDQTIRFDHVITNMN NNYEPRSGKFTCKVPGLYYFTYHASSRGNLCVNLMRGRERAQKVVTFCDY AYNTFQVTTGGMVLKLEQGENVFLQATDKNSLLGMEGANSIFSGFLLFPD MEA
-
分子量
26.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1qB is a crucial component of the complement system, specifically part of the C1 complex involved in the classical pathway of complement activation. The complement system plays a critical role in the immune response, facilitating opsonization, inflammation, and cell lysis. Research on C1qB has gained significant attention due to its dual role in both normal physiological processes and various pathological conditions, including autoimmune diseases and infections. Understanding the structure and function of C1qB is vital for deciphering its involvement in complement-mediated processes. Advances in recombinant protein technology have enabled the expression and purification of C1qB, facilitating studies on its interactions with other complement proteins and immune cells. Furthermore, investigating the therapeutic potential of C1qB-targeted treatments may lead to novel strategies for modulating immune responses in diseases where the complement system plays a key role. As such, the study of C1qB recombinant proteins not only enhances our understanding of immune system dynamics but also opens avenues for potential clinical applications.
